Mirtazapine
Mirtazapine (Remeron) is an antidepressant for major depressive disorder in adults. This catalogue lists the Remeron tablet and its available strength options for people researching this medicine.
Key points
- Boxed warning: In short-term studies, antidepressants increased the risk of suicidal thoughts and behaviours in paediatric and young adult patients.
- Sore throat or fever: If these occur with stomatitis or signs of infection and a low white blood cell count, mirtazapine treatment should be discontinued and closely monitored.
- Appetite, weight and alertness: Mirtazapine has been associated with increased appetite and weight gain, and sleepiness may affect judgement, thinking or motor skills.
Brands and forms in this catalogue
The listed mirtazapine medicine is Remeron, an Organon originator line. It is listed as a tablet for Major Depressive Disorder and sits in Antidepressants.
Further reading
Related articles
29 Jul 2026 ⋅ 9 min read
Antidepressants: The Boxed Warning, the First Few Weeks, and Stopping Safely
Every antidepressant carries a boxed warning about suicidal thoughts in young people, the risk concentrates early in treatment, and stopping abruptly causes withdrawal symptoms. What to expect and what to watch for.
Read guide